HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,494,821 | -67.8% | 16,687 | -69.4% | 0.00% | -66.7% |
| Q2 2023 | $4,647,197 | +99.4% | 54,583 | +93.8% | 0.01% | +71.4% |
| Q1 2023 | $2,330,654 | -73.1% | 28,165 | -74.4% | 0.01% | -74.1% |
| Q4 2022 | $8,659,365 | +55.3% | 110,100 | +46.2% | 0.03% | +42.1% |
| Q3 2022 | $5,577,000 | -67.3% | 75,329 | -71.2% | 0.02% | -66.1% |
| Q2 2022 | $17,042,000 | -40.2% | 261,454 | -42.0% | 0.06% | -33.3% |
| Q1 2022 | $28,492,000 | +26.4% | 450,679 | +6.1% | 0.08% | +75.0% |
| Q4 2021 | $22,536,000 | -34.8% | 424,895 | -13.2% | 0.05% | -37.7% |
| Q3 2021 | $34,539,000 | +95.1% | 489,284 | +84.1% | 0.08% | +92.5% |
| Q2 2021 | $17,707,000 | +29.4% | 265,716 | +115.5% | 0.04% | +11.1% |
| Q1 2021 | $13,687,000 | +299.7% | 123,291 | +327.6% | 0.04% | +260.0% |
| Q4 2020 | $3,424,000 | -85.4% | 28,830 | -89.3% | 0.01% | -88.0% |
| Q3 2020 | $23,439,000 | +18.8% | 268,646 | +22.0% | 0.08% | -15.3% |
| Q2 2020 | $19,726,000 | +305.6% | 220,252 | +351.3% | 0.10% | +145.0% |
| Q1 2020 | $4,863,000 | -81.7% | 48,800 | -78.9% | 0.04% | -50.0% |
| Q4 2019 | $26,561,000 | +227.7% | 231,162 | +259.7% | 0.08% | +196.3% |
| Q3 2019 | $8,106,000 | +287.3% | 64,259 | +269.5% | 0.03% | +285.7% |
| Q2 2019 | $2,093,000 | -76.1% | 17,393 | -82.7% | 0.01% | -75.0% |
| Q1 2019 | $8,774,000 | +91.4% | 100,300 | +118.9% | 0.03% | +55.6% |
| Q4 2018 | $4,585,000 | -49.2% | 45,825 | -54.5% | 0.02% | -33.3% |
| Q2 2018 | $9,031,000 | +1345.0% | 100,701 | +1078.9% | 0.03% | +1250.0% |
| Q1 2018 | $625,000 | -95.6% | 8,542 | -96.5% | 0.00% | -95.7% |
| Q4 2017 | $14,173,000 | +2440.0% | 244,023 | +1861.0% | 0.05% | +2200.0% |
| Q3 2017 | $558,000 | +105.9% | 12,444 | +66.2% | 0.00% | +100.0% |
| Q3 2016 | $271,000 | -86.8% | 7,488 | -87.3% | 0.00% | -90.0% |
| Q1 2016 | $2,054,000 | +584.7% | 58,730 | +582.9% | 0.01% | +900.0% |
| Q3 2014 | $300,000 | -93.5% | 8,600 | -93.4% | 0.00% | -95.2% |
| Q2 2014 | $4,622,000 | -35.3% | 131,007 | -40.2% | 0.02% | -44.7% |
| Q1 2014 | $7,143,000 | +1565.0% | 219,188 | +2054.6% | 0.04% | +1800.0% |
| Q4 2013 | $429,000 | – | 10,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |